Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel C Jankowitz

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Familial Cancer|May 31, 2012
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancerNatalie J Engel, Patricia Gordon, Darcy L Thull, et al.
Scientific Reports|May 20, 2017
DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer PresenceShandong Wu, Margarita L Zuley, Wendie A Berg, et al.
Breast Cancer Research : BCR|October 18, 2011
Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancerRachel C Jankowitz, Kristine Cooper, Mark G Erlander, et al.
JCO Oncology Practice|March 12, 2021
Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 PandemicKathryn Hawrot, Lawrence N Shulman, Ira J Bleiweiss, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the BreastAju Mathew, Padma S Rajagopal, Vipin Villgran, et al.
Breast Cancer Research : BCR|July 25, 2016
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancerShandong Wu, Wendie A Berg, Margarita L Zuley, et al.
Journal of Clinical and Translational Science|October 13, 2023
Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUMHarriet T Rothschild, A Jo Chien, Rachel C Jankowitz, et al.
Breast Cancer Research : BCR|June 5, 2015
Molecular drivers of lobular carcinoma in situGreg J Logan, David J Dabbs, Peter C Lucas, et al.
Oncology Nursing Forum|October 31, 2014
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancerTheresa A Koleck, Catherine M Bender, Susan M Sereika, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I studyRachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Familial Cancer|May 31, 2012
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancerNatalie J Engel, Patricia Gordon, Darcy L Thull, et al.
Scientific Reports|May 20, 2017
DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer PresenceShandong Wu, Margarita L Zuley, Wendie A Berg, et al.
Breast Cancer Research : BCR|October 18, 2011
Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancerRachel C Jankowitz, Kristine Cooper, Mark G Erlander, et al.
JCO Oncology Practice|March 12, 2021
Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 PandemicKathryn Hawrot, Lawrence N Shulman, Ira J Bleiweiss, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2017
Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the BreastAju Mathew, Padma S Rajagopal, Vipin Villgran, et al.
Breast Cancer Research : BCR|July 25, 2016
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancerShandong Wu, Wendie A Berg, Margarita L Zuley, et al.
Journal of Clinical and Translational Science|October 13, 2023
Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUMHarriet T Rothschild, A Jo Chien, Rachel C Jankowitz, et al.
Breast Cancer Research : BCR|June 5, 2015
Molecular drivers of lobular carcinoma in situGreg J Logan, David J Dabbs, Peter C Lucas, et al.
Oncology Nursing Forum|October 31, 2014
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancerTheresa A Koleck, Catherine M Bender, Susan M Sereika, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2013
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I studyRachel C Jankowitz, Jame Abraham, Antoinette R Tan, et al.
Pageof 6